# Ajooni Biotech (NSE: AJOONI) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/AJOONI · Pivot · prices to 22 Oct 2026

Ajooni Biotech (NSE: AJOONI) closed at ₹2.87 on 22 Oct 2026, down 0.35% on the day. With a market capitalisation of ₹49 Cr, it ranks 3082nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Packaged Foods.

At its last close the stock traded at 14.3× trailing earnings, against a return on equity of 3.8% in FY25. Over the past year the share price has fallen 44.1%. Its 52-week range is ₹2.68 (12 Oct 2026) to ₹5.50 (9 Feb 2026); the last close is 47.8% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹61 Cr (+107.1% year on year) and net profit ₹1 Cr (−38.3%), on a standalone basis. Promoters held 26.89% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹2.87 |
| Market cap | ₹49 Cr |
| P/E (trailing) | 14.3 |
| ROE | 3.8% (FY25) |
| ROCE | 5.2% (FY25) |
| Debt to equity | 0.06 |
| 52-week high | ₹5.50 (9 Feb 2026) |
| 52-week low | ₹2.68 (12 Oct 2026) |
| 1-year return | −44.1% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹61 Cr | +107.1% | ₹1 Cr | −38.3% | ₹0.05 |
| Q3 FY26 | ₹59 Cr | +72.6% | ₹2 Cr | +126.0% | ₹0.10 |
| Q2 FY26 | ₹32 Cr | +23.4% | ₹1 Cr | +50.0% | ₹0.08 |
| Q1 FY26 | ₹31 Cr | +21.9% | ₹1 Cr | +66.0% | ₹0.02 |
| Q4 FY25 | ₹29 Cr | +49.5% | ₹2 Cr | +69.2% | ₹0.09 |
| Q3 FY25 | ₹34 Cr | +69.7% | ₹1 Cr | +65.9% | ₹0.04 |
| Q2 FY25 | ₹26 Cr | +32.0% | ₹1 Cr | +55.0% | ₹0.04 |
| Q1 FY25 | ₹26 Cr | +22.2% | ₹0 Cr | +17.5% | ₹0.03 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹115 Cr | ₹3 Cr |
| FY24 | ₹80 Cr | ₹2 Cr |
| FY23 | ₹74 Cr | ₹1 Cr |
| FY22 | ₹74 Cr | ₹1 Cr |
| FY21 | ₹51 Cr | ₹0 Cr |
| FY20 | ₹40 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 26.89%
- Non-institutions: 73.11%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Warren Tea](https://app.pivotnow.in/stock/WARRENTEA) | — | ₹54 Cr | — | — |
| [Anjani Foods](https://app.pivotnow.in/stock/ANJANIFOODS) | — | ₹48 Cr | — | — |
| [Prudential Sugar Corporation](https://app.pivotnow.in/stock/PRUDMOULI) | ₹14.30 | ₹46 Cr | 7.7 | — |
| [Kretto Syscon](https://app.pivotnow.in/stock/KRETTOSYS) | — | ₹46 Cr | — | — |
| [Roni Households](https://app.pivotnow.in/stock/RONI) | — | ₹45 Cr | — | — |
| [Growington Vent](https://app.pivotnow.in/stock/GROWINGTON) | — | ₹45 Cr | — | — |

## Questions and answers

### What is the share price of Ajooni Biotech today?

Ajooni Biotech (NSE: AJOONI) last closed at ₹2.87 on 22 Oct 2026. Its 52-week high is ₹5.50 and its 52-week low is ₹2.68.

### What is the market cap of Ajooni Biotech?

Ajooni Biotech's market capitalisation is ₹49 Cr (₹49 Cr) at the 22 Oct 2026 close, ranking 3082nd among the NSE companies Pivot tracks.

### What is the P/E ratio of Ajooni Biotech?

Ajooni Biotech trades at a trailing P/E of 14.3.

### What is the ROE and ROCE of Ajooni Biotech?

Return on equity was 3.8% in FY25 and return on capital employed was 5.2% in FY25 (standalone figures).

### Is Ajooni Biotech a debt-free company?

No. Ajooni Biotech's debt-to-equity ratio was 0.06 in FY25, with total debt of ₹2 Cr.

### What were Ajooni Biotech's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Ajooni Biotech reported revenue of ₹61 Cr, +107.1% year on year, and net profit of ₹1 Cr, −38.3% year on year.

### How has Ajooni Biotech stock performed over the last year?

Ajooni Biotech's share price has fallen 44.1% over the past year, −28.6% over three months and −10.0% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Ajooni Biotech?

As of 30 Jun 2026: promoters 26.89%, non-institutions 73.11%.

### Who are Ajooni Biotech's competitors?

The listed FMCG companies closest to Ajooni Biotech by market cap are Warren Tea, Anjani Foods, Prudential Sugar Corporation, Kretto Syscon, Roni Households and Growington Vent.

### Is Ajooni Biotech a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Ajooni Biotech's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AJOONI against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.